We support a wide range of state-of-the-art molecular diagnostic platforms and technologies that allow for development and customization of any assay. We can facilitate direct assay transfer of an existing test or undertake full development of a new assay through clinical validation.
In addition, our high quality testing services enable immediate scalability and commercialization of your assay. As one of the largest single-site, state-of-the-art laboratories in the country, we have the capacity and flexibility to tailor our services and choose the best solution for clients of all sizes.
CRL’s team of experienced, multi-disciplinary Ph.D. scientists provides the necessary breadth and depth of expertise to meet your testing needs, across all phases of development and project complexity, in both research and clinical applications.
As a CAP accredited and CLIA certified laboratory, CRL specializes in the development of laboratory developed tests (LDTs). All of our testing services are extensively validated for accuracy and reliability and subjected to routine audits. Our licensures, including New York State, enable CRL to provide unified commercial and clinical testing services on samples collected across the United States and globally.
CRL offers a comprehensive, fully customizable and continually expanding menu of molecular diagnostics tests and services.Browse Our Test Catalog
Start a conversation for information about tests not listed or for a custom project consultation.
Start a conversation